The US Food and Drug Administration (FDA) has granted 510(k) clearance to Biosign Technologies' non-invasive blood pressure measurement system, Pulsewave monitor. The UFIT EN-10 monitor is worn on the wrist having 13.5 cm to 23 cm (5.3 ...
Tags: FDA, blood pressure measurement system, pulsewave monitor, systolic
The US Food and Drug Administration (FDA) has granted 510(k) clearances to Hollywog's new WiTouch and WiTouch Pro wireless remote controlled devices. The WiTouch devices, which incorporates TENS technology, are designed for the ...
Tags: FDA, treatment of back pain, wireless remote controlled device
DenMat has entered into an agreement to purchase US-based PeriOptix,a provider of magnification and illumination technologies for dental industry. PeriOptix commercial products include Air-X super-light frame system,designed to be worn ...
Tags: DenMat, PeriOptix, dental industry, purchase
QualChoice Health Insurance has implemented TriZetto’s payment bundling solution software to administer episode based payments to physicians who cater cardiac stents, perinatal care and hip and knee replacements for its group and ...
Tags: payment bundling, QualChoice Health Insurance, Health Insurance
Aptalis Pharma, a specialty pharmaceutical company, has announced the commercial availability of Viokace (pancrelipase) tablets in the US. Viokace, in combination with a proton pump inhibitor, is indicated in adults for the treatment of ...
Rocky Brands Inc. has added two collections expanding the company's footprint into the outdoor adventure market and creating a new footwear option for healthcare professionals. Rocky S2V for the outdoor adventure segment will be available ...
Tags: Rocky Brands, collections, footwear
Computerworld - Federal investigators Thursday released a report charging that the Medicare electronic medical records (EMR) program lacks effective fiscal oversight. The report, issued by the Inspector General's office of the Department ...
Tags: Protection, Oversight, Security
Hospira has announced a nationwide voluntary recall of one lot of Hydromorphone Injection, USP, 2mg/mL (C-II), 1mL fill in 2.5mL Carpuject, NDC 0409-1312-30 , due to a reported complaint of a single Carpuject containing more than the 1mL ...
Novartis has commenced shipment of Fluvirin influenza vaccine for the 2012-2013 influenza season, in the US. Novartis plans to ship more than 30 million doses of the Fluvirin vaccine which has been reformulated to include two new ...
Tags: Novartis, fluvirin influenza seasonal vaccine, seasonal influenza
AstraZeneca has published a new study that demonstrates that Symbicort Inhalation Aerosol 320/9 μg twice daily has a safety profile similar to Budesonide pressurized metered-dose inhaler (pMDI) 320 μg twice daily for asthma. In a ...
Tags: asthma, drug relationship, use of Symbicort
BioSyent Pharma, a subsidiary of BioSyent, has signed an exclusive licensing and distribution agreement with an undisclosed European partner for two new products, which will be marketed by its' Hospital Products Division. The two products ...
Tags: BioSyent Pharma, BioSyent, two new products, pharmaceutical products
Purdue Pharma has announced the availability of Intermezzo sublingual tablet CIV in 1.75mg and 3.5mg dosage strengths for insomnia characterized by middle-of-the-night awakenings followed by difficulty returning to sleep. ...
Tags: Purdue Pharma, Insomnia Drug, Intermezzo sublingual tablet CIV
Covidien, a provider of healthcare products, has opened a new China Technology Center (CTC) Research and Development (R&D) facility in Shanghai, China. The $45m facility focuses on identifying and developing products that meet the needs ...
Tags: healthcare products, China Technology Center, medical technology
Australian Therapeutic Goods Administration (TGA) has cleared Genzyme's once daily oral Aubagio 14mg dose for the treatment of relapsing multiple sclerosis (MS). Aubagio, which has anti-inflammatory properties, is expected to minimize ...
Healthcare organisations are embracing mobile working like never before,but the issue around network coverage is causing concern. A new study from software company NDL showed projects to test out the validity of mobile working were moving ...
Tags: Network health, Healthcare organisations, network coverage